Skip to content

The Results of Total Hip Arthroplasty in Crowe Type 4 Hips.

At Least 10-Year Results of Cementless Ceramic-On-Ceramic Total Hip Arthroplasty Performed With Transverse Subtrochanteric Osteotomy in Crowe Type 4 Hips.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04834492
Enrollment
67
Registered
2021-04-08
Start date
2020-07-15
Completion date
2021-03-30
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Results of Total Hip Arthroplasty in Crowe Type 4 Dysplastic Hips

Keywords

Developmental dysplasia of the hip, total hip arthroplasty, transverse subtrochanteric shortening osteotomy, ceramic on ceramic, cementless.

Brief summary

Total hip arthroplasty (THA) performed for developmental dysplasia of the hip (DDH) is a technically difficult procedure with a high complication rate, especially in the presence of completely dislocated hips. This study aimed to evaluate the results of at least 10 years of follow-up results of cementless, ceramic-on-ceramic (CoC) total hip arthroplasty performed with transverse subtrochanteric osteotomy in Crowe type 4 hips.

Detailed description

We reviewed retrospectively 67 hips of 50 patients which underwent CoC, cementless THA with transverse subtrochanteric osteotomy between 2008 and 2011. Clinical and radiological data of the hips were examined. Clinical results were evaluated using the Harris Hip Score (HHS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).

Interventions

PROCEDURETotal hip arthroplasty

Total hip arthroplasty in Crowe type 4 developmental dysplasia of the hip.

Sponsors

Private Ortopedia Hospital, Seyhan Adana
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

Crowe type 4 developmental dysplasia of the hip

Exclusion criteria

Primary Coxarthrosis

Design outcomes

Primary

MeasureTime frameDescription
Clinical resultsminimum 10 year follow-upHaris Hip Score

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026